loading
Schlusskurs vom Vortag:
$10.55
Offen:
$10.54
24-Stunden-Volumen:
153
Relative Volume:
0.01
Marktkapitalisierung:
$230.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$4.76M
KGV:
48.53
EPS:
0.2172
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
+0.29%
6M Leistung:
+1.93%
1J Leistung:
+4.67%
1-Tages-Spanne:
Value
$10.54
$10.54
1-Wochen-Bereich:
Value
$10.54
$10.56
52-Wochen-Spanne:
Value
$10.05
$10.56

Translational Development Acquisition Corp Stock (TDAC) Company Profile

Name
Firmenname
Translational Development Acquisition Corp
Name
Telefon
(413) 204-2769
Name
Adresse
52 E 83RD ST., NEW YORK
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
TDAC's Discussions on Twitter

Compare TDAC vs LION, XXI, UMAC, DMII, BCSS

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Shell Companies icon
TDAC
Translational Development Acquisition Corp
10.54 230.91M 0 4.76M 0 0.2172
Shell Companies icon
LION
Lionsgate Studios Corp
9.74 2.86B 2.80B -224.60M -1.10M -0.8751
Shell Companies icon
XXI
Twenty One Capital Inc
6.845 2.33B 0 4.35M 456.40K 0.3397
Shell Companies icon
UMAC
Unusual Machines Inc
20.83 844.13M 0 -5.28M -3.11M -0.6947
Shell Companies icon
DMII
Drugs Made In America Acquisition Ii Corp
9.94 652.45M 0 0 0 -0.0028
Shell Companies icon
BCSS
Bain Capital Gss Investment Corp
10.14 592.18M 0 0 0 0.00

Translational Development Acquisition Corp Stock (TDAC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2021-09-21 Eingeleitet Northland Capital Outperform

Translational Development Acquisition Corp Aktie (TDAC) Neueste Nachrichten

pulisher
Mar 12, 2026

Aug Macro: Is Translational Development Acquisition Corp attractive at current valuation2026 Volatility Report & Verified Short-Term Plans - baoquankhu1.vn

Mar 12, 2026
pulisher
Mar 07, 2026

Buy Signal: How liquid is TBCPW stock2025 Stock Rankings & Smart Allocation Stock Tips - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 06, 2026

Volatility Watch: Is AEye Inc stock risky to hold nowTrade Exit Summary & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 05, 2026

Latest Lab Talk News in Brief: investment, acquisition, collaboration, R&D, awards, appointments - Laboratory Talk

Mar 05, 2026
pulisher
Mar 04, 2026

IPO Launch: Should you avoid TPST stock right nowAnalyst Downgrade & Low Risk Investment Opportunities - baoquankhu1.vn

Mar 04, 2026
pulisher
Feb 26, 2026

TDAC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

Stock Recap: Is LCII a speculative investmentMarket Movers & AI Enhanced Market Trend Forecasts - baoquankhu1.vn

Feb 26, 2026
pulisher
Feb 25, 2026

Movement Recap: Can Translational Development Acquisition Corp Equity Warrant expand its profit marginsPortfolio Update Report & Fast Exit Strategy with Risk Control - baoquankhu1.vn

Feb 25, 2026
pulisher
Feb 21, 2026

Stock Analysis: Will CIMG Inc announce a stock split2025 Short Interest & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Feb 21, 2026
pulisher
Feb 20, 2026

Published on: 2026-02-21 02:25:17 - mfd.ru

Feb 20, 2026
pulisher
Feb 20, 2026

Published on: 2026-02-21 08:39:55 - baoquankhu1.vn

Feb 20, 2026
pulisher
Feb 19, 2026

Volume Report: Is CICXU currently under institutional pressureEarnings Overview Summary & Accurate Buy Signal Alerts - baoquankhu1.vn

Feb 19, 2026
pulisher
Feb 18, 2026

Axol Bioscience makes third acquisition in five years - Business Weekly

Feb 18, 2026
pulisher
Feb 18, 2026

Axol Bioscience acquires ophthalmology business from Newcells Biotech - Cambridge Network

Feb 18, 2026
pulisher
Feb 14, 2026

Can Translational Development Acquisition Corp. Equity Warrant stock double in next 5 yearsEntry Point & Daily Profit Maximizing Trade Tips - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Why Critical Metals Corp. stock could outperform in 2025Quarterly Market Review & Technical Entry and Exit Alerts - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

Why NOVA stock remains resilientJuly 2025 Catalysts & Safe Capital Preservation Plans - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

Growth Review: What hedge funds are buying BJRIPortfolio Risk Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Feb 13, 2026
pulisher
Feb 13, 2026

What’s the profit margin of Translational Development Acquisition Corp.Share Buyback & Free Low Drawdown Momentum Trade Ideas - mfd.ru

Feb 13, 2026
pulisher
Feb 12, 2026

Will Translational Development Acquisition Corp. stock remain a Wall Street favoritePortfolio Gains Report & Community Verified Swing Trade Signals - mfd.ru

Feb 12, 2026
pulisher
Feb 10, 2026

What drives Translational Development Acquisition Corp.’s stock price2025 Trading Recap & Verified Swing Trading Watchlist - mfd.ru

Feb 10, 2026
pulisher
Feb 09, 2026

Big Picture: What are ClearPoint Neuro Incs recent SEC filings showingIPO Watch & Growth Focused Stock Reports - baoquankhu1.vn

Feb 09, 2026
pulisher
Feb 08, 2026

CEO Moves: Is Albany International Corps growth already priced in2025 Pullback Review & Weekly Sector Rotation Insights - baoquankhu1.vn

Feb 08, 2026
pulisher
Feb 06, 2026

Aug Drivers: What is the dividend yield of QUALCOMM IncorporatedJuly 2025 Institutional & Long-Term Safe Return Strategies - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 06, 2026

Risk On: Can PSAPRF outperform under higher oil pricesJuly 2025 Macro Moves & Community Trade Idea Sharing Platform - baoquankhu1.vn

Feb 06, 2026
pulisher
Feb 06, 2026

Will Zeta Global Holdings Corp. stock split attract more investors2025 Macro Impact & AI Forecast Swing Trade Picks - mfd.ru

Feb 06, 2026
pulisher
Feb 04, 2026

Why is Translational Development Acquisition Corp. Equity Warrant stock going downMarket Growth Summary & Weekly Return Optimization Plans - mfd.ru

Feb 04, 2026
pulisher
Feb 03, 2026

Aug Shorts: Is Translational Development Acquisition Corp. a potential multi baggerBull Run & Weekly Return Optimization Plans - baoquankhu1.vn

Feb 03, 2026
pulisher
Feb 03, 2026

Pharmagene Discovery Services Launches Following Acquisition of Human Tissue Laboratory - Lab Manager

Feb 03, 2026
pulisher
Feb 01, 2026

Pullback Watch: Whats next for ALRS stockJuly 2025 Movers & Long Hold Capital Preservation Tips - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 31, 2026

Published on: 2026-02-01 08:56:35 - baoquankhu1.vn

Jan 31, 2026
pulisher
Jan 27, 2026

Energy Moves: Can Translational Development Acquisition Corp outperform in the next rallyWeekly Market Report & Stock Portfolio Risk Control - baoquankhu1.vn

Jan 27, 2026
pulisher
Jan 27, 2026

Update Report: Is Translational Development Acquisition Corp undervalued by DCF analysisEarnings Growth Summary & Daily Profit Maximizing Trade Tips - baoquankhu1.vn

Jan 27, 2026
pulisher
Jan 26, 2026

Bear Alert: Whats the profit margin of Translational Development Acquisition CorpWeekly Trade Summary & AI Enhanced Trading Alerts - baoquankhu1.vn

Jan 26, 2026
pulisher
Jan 25, 2026

Short Covering: What is EDUCs 5 year growth outlookMarket Trend Review & Free Verified High Yield Trade Plans - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 24, 2026

Investment Recap: Can Translational Development Acquisition Corp Equity Warrant expand its profit marginsJuly 2025 Recap & Short-Term Trading Opportunity Alerts - baoquankhu1.vn

Jan 24, 2026
pulisher
Jan 24, 2026

Is Trinity Capital Inc stock showing strong momentumTrade Analysis Summary & High Yield Stock Recommendations - baoquankhu1.vn

Jan 24, 2026
pulisher
Jan 23, 2026

Is Qualigen Therapeutics Inc stock a value trap2025 Technical Overview & Daily Momentum Trading Reports - baoquankhu1.vn

Jan 23, 2026
pulisher
Jan 22, 2026

Resalis Therapeutics Appoints Sandor Batkai as Medical Director - The Manila Times

Jan 22, 2026
pulisher
Jan 21, 2026

Aug Fed Impact: Why is Translational Development Acquisition Corp Equity Warrant stock going downEarnings Beat & Detailed Earnings Play Alerts - baoquankhu1.vn

Jan 21, 2026
pulisher
Jan 19, 2026

Earnings Beat: Can Translational Development Acquisition Corp outperform in the next rally2025 Market Overview & Verified Entry Point Detection - baoquankhu1.vn

Jan 19, 2026
pulisher
Jan 19, 2026

Is Translational Development Acquisition Corp. stock oversold or undervaluedEarnings Summary Report & Short-Term High Return Ideas - bollywoodhelpline.com

Jan 19, 2026
pulisher
Jan 19, 2026

Why Translational Development Acquisition Corp. Equity Warrant stock is recommended by analystsJuly 2025 WrapUp & Smart Allocation Stock Tips - bollywoodhelpline.com

Jan 19, 2026
pulisher
Jan 19, 2026

Is Heritage Insurance Holdings Inc stock a hidden gemJuly 2025 Movers & Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Jan 19, 2026
pulisher
Jan 18, 2026

What catalysts could drive Vision Marine Technologies Inc. stock higherMarket Sentiment Report & Daily Entry Point Trade Alerts - bollywoodhelpline.com

Jan 18, 2026
pulisher
Jan 18, 2026

What hedge fund moves indicate for General Electric Company (GCP) stockQuarterly Profit Report & Proven Capital Preservation Tips - bollywoodhelpline.com

Jan 18, 2026
pulisher
Jan 18, 2026

Smart Money: Whats the profit margin of Translational Development Acquisition CorpJuly 2025 Chart Watch & Daily Stock Momentum Reports - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 17, 2026

Quarterly Earnings: What are Spring Valley Acquisition Corp IIs earnings expectationsQuarterly Portfolio Summary & Long-Term Capital Growth Strategies - baoquankhu1.vn

Jan 17, 2026
pulisher
Jan 16, 2026

Published on: 2026-01-17 09:56:53 - baoquankhu1.vn

Jan 16, 2026
pulisher
Jan 15, 2026

Investment Recap: Whats next for DXLG stockMarket Trend Review & Risk Controlled Swing Trade Alerts - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 13, 2026

IPO Launch: Is Beasley Broadcast Group Inc in a bullish channelMarket Volume Summary & Verified Momentum Watchlists - baoquankhu1.vn

Jan 13, 2026

Finanzdaten der Translational Development Acquisition Corp-Aktie (TDAC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$10.09
price up icon 0.15%
$11.14
price up icon 0.13%
$10.14
price down icon 0.10%
$10.07
price up icon 0.10%
$10.30
price down icon 0.39%
$10.14
price down icon 0.10%
Kapitalisierung:     |  Volumen (24h):